Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

A holistic approach is crucial for treating skin disorders and restoring barrier function.

Alopecia areata in children is caused by the immune system attacking hair follicles due to genetic factors.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

Researchers found two genes that may explain why some Casertana pigs don't have hair.

Dual TCR Treg cells are common in mouse tissues and vary by location.

Dual TCR Treg cells are common in various mouse tissues and show diverse characteristics.

Innate lymphoid cells help us understand and manage allergic diseases better.

TLR3 signaling enhances the immunosuppressive properties of human periodontal ligament stem cells.

Certain plasma proteins and genes are linked to obstructive sleep apnea, suggesting potential new treatments.

Human hair follicle cells can help regenerate hair and reduce inflammation, aiding in hair loss treatment.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

Artificial skin grafts face immune rejection, but stem cells may improve future designs.

Loss of Msx2 function causes eye development issues similar to Peters anomaly.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Blocking IL-17a can improve age-related smell loss in mice.

miR-21 helps improve ovarian function recovery in treated mice.

IL-18 signaling helps mature Tregs move into the thymus.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Immune-epithelial interactions are crucial for tissue repair, but unchecked can cause diseases.

Targeting JAK-STAT1 can reduce inflammation and promote hair growth in conditions linked to EGFR deficiency.

Some cells may slow melanoma growth, a protein could affect skin pigmentation, a gene-silencing method might treat hair defects, skin bacteria changes likely result from eczema, and a defensin protein could help treat multiple sclerosis.

New findings suggest potential treatments for melanoma, hyperpigmentation, hair defects, and multiple sclerosis, and show skin microbiome changes don't cause atopic dermatitis.

NDP-MSH protects brain cells and reduces inflammation in Parkinson's disease by activating MC1R and involving Tregs.

Some viruses can cause cancer by changing cell processes and avoiding the immune system; vaccines and targeted treatments help reduce these cancers.